Medical-Surgical Endocrine Practice Test

The main idea being tested is that HbA1c targets for adults with diabetes are individualized based on balancing glycemic benefit with potential risks. For most nonpregnant adults, aiming for an HbA1c below 7% reduces microvascular complications without excessive harm from hypoglycemia or treatment load. There are important exceptions: for younger, healthier patients who can avoid hypoglycemia and adhere to intensive therapy, a tighter target such as less than 6.5% can be appropriate. For older individuals or those with multiple comorbidities, limited life expectancy, or a high risk of hypoglycemia, a less stringent goal, around 7.5% to 8%, is often more suitable. Pregnancy-related targets are different and not part of this nonpregnant scenario, and targets should be tailored to the individual rather than applied uniformly.